Page 49 - GB-RI-PierreFabre-Complet-INTERACTIF

INTERVIEW Learning from each other Committed to our stakeholders Li Hang, Director of Dermatology at the Peking University First Hospital Kyung-Ae Choe, Managing Director PFDC China Xavier Ormancey, Director of Dermo- Cosmetics R&D What are the goals of this partnership between the Peking University First Hospital and Pierre Fabre? Li Hang This project paves the way for a new model of cooperation between university research and the operational excellence of a company. We are going to learn from each other and prove that this collaboration will equal more than the sum of its parts! Xavier Ormancey This partnership makes a lot of sense. We intend to develop specific products and test both their efficacy and how consumers perceive them. The historic roots of the University of Peking and the richness of its network will help us to validate the safety and efficacy of certain active ingredients. Kyung-Ae Choe In a highly competitive environment, we want to highlight the Group's medical image. The reputation of this prestigious partner, the only one to be recognized by the government, is a fundamental advantage. In order to adapt our formulas to regulations, we also need a local R&D center, which is now possible thanks to this alliance. What are the expected advantages for consumers? L. H. Pierre Fabre will get a better understanding of the specific needs of Chinese consumers and patients, while Chinese dermatologists will be able to rely on a major laboratory's know-how and ability to innovate. K.-A.C. - This collaboration is indeed a wonderful opportunity for both sides to better understand the specific features of the Chinese skin. Ultimately, the aim is to offer better products which are better suited to local consumers. X. O. Understanding specific needs will allow us to stand out on the Chinese market thanks to breakthrough textures and sensations. But this can also inspire us for future international products, and this is the whole point of development diversification. What will the first phases of this collaboration be? L. H. We intend to pave the way for an efficient collaboration, in order to facilitate scientific exchanges. We will also be initiating a first joint research project. I am certain that ideas will abound as soon as we have laid down the partnership in concrete terms. K.-A.C. - In addition to two clinical studies on sensitive skin, we intend to organize a number of events to raise awareness among Chinese consumers about skin care – bearing in mind that access to a dermatologist is not easy in China –, and also an annual medical summit to address new subjects. The Group's expertise in skin cancer is particularly recognized and appreciated by the university and by Chinese dermatologists. CREATING VALUE 45